STI screening recommendations in pregnant and post-partum women

STI testing guidelines for pregnant and post-partum women have recently changed in WA to reduce the risk of negative health outcomes in both the mother and neonate.

  Women living in WA* Women living in regions affected by the ongoing outbreak in Aboriginal  communities, i.e. Kimberley, Pilbara and Goldfields*
At booking visit
  • Chlamydia and gonorrhoea (SOLVS/ cervix/ throat/ anus)
  • Hepatitis B and C serology
  • Syphilis serology
  • HIV serology
  • Chlamydia and gonorrhoea (SOLVS/ cervix/ throat/ anus)
  • Hepatitis B and C serology
  • Syphilis serology
  • HIV serology
28 weeks**
  • Syphilis serology
  • Syphilis serology
  • HIV serology

36 weeks or at time of any preterm birth

  • Syphilis serology
  • Chlamydia and gonorrhoea (SOLVS/ cervix/ throat/ anus)
  • Syphilis serology
Delivery
  • Syphilis serology
6 weeks post-partum**
  • Syphilis serology

*More frequent testing may be indicated for pregnant/ birthing women on a case-by-case basis if they have STI symptoms, unsafe sex and/or partner change in between these testing intervals. STI risk is higher in women to whom one or more of the following risk factors apply

  • one or more new sexual partners after her first syphilis blood test in pregnancy
  • a sexual partner who is a man who has sex with men
  • sexual partners who have had one or more new sexual partners after the woman became pregnant
  • infectious syphilis in a previous pregnancy
  • a sexually transmitted infection during the current pregnancy or within the previous 12 months
  • has used methamphetamine and/ or injected drugs in the previous 12 months
  • is a person who is from, or has had sex with someone who is from a high prevalence country
  • is a person experiencing homelessness
  • is an Aboriginal person
  • is from a geographical area with high prevalence of one or more of the above risk factors

** The mental health assessment (including screening for drug and alcohol use and domestic violence) conducted at 28 weeks as part of MBS items 16590 and 16590 and at 6 weeks post-partum as part of MBS item number 16407 can be used to identify women at risk of STIs.

Last reviewed: 24-03-2021